{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:07:01Z","timestamp":1784765221510,"version":"3.55.0"},"reference-count":56,"publisher":"Impact Journals, LLC","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,8,15]]},"DOI":"10.18632\/oncotarget.18963","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T19:17:45Z","timestamp":1499195865000},"page":"54858-54872","source":"Crossref","is-referenced-by-count":6,"title":["Hyperactivated mTORC1 downregulation of FOXO3a\/PDGFR\u03b1\/AKT cascade restrains tuberous sclerosis complex-associated tumor development"],"prefix":"10.18632","volume":"8","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofei","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuquan","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keguo","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Third Affiliated Hospital of Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Parasitology, School of Basic Medicine, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Molecular Biology, Department of Physiology and Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongdong","family":"Hu","sequence":"additional","affiliation":[{"name":"Modern Research Center for Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zha","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.201306041","article-title":"Where is mTOR and what is it doing there?","volume":"203","author":"Hall","year":"2013","journal-title":"J Cell Biol"},{"key":"3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Sabatini","year":"2007","journal-title":"Cancer Cell"},{"key":"4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Guan","year":"2015","journal-title":"J Clin Invest"},{"key":"5","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Sabatini","year":"2009","journal-title":"J Cell Sci"},{"key":"6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1128\/MCB.00782-08","article-title":"Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin","volume":"29","author":"Foster","year":"2009","journal-title":"Mol Cell Biol"},{"key":"7","first-page":"e27","article-title":"New insights into mTOR signaling: mTORC2 and beyond","volume":"2","author":"Garcia-Martinez","year":"2009","journal-title":"Sci Signal"},{"key":"8","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Sonenberg","year":"2004","journal-title":"Genes Dev"},{"key":"9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Henske","year":"2006","journal-title":"N Engl J Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJMcibr1406613","article-title":"Molecular basis of giant cells in tuberous sclerosis complex","volume":"371","author":"Manning","year":"2014","journal-title":"N Engl J Med"},{"key":"11","doi-asserted-by":"publisher","first-page":"61152","DOI":"10.18632\/oncotarget.10748","article-title":"Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2","volume":"7","author":"Kristof","year":"2016","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Manning","year":"2008","journal-title":"Biochem J"},{"key":"13","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.18632\/oncotarget.2206","article-title":"Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients","volume":"5","author":"Habib","year":"2014","journal-title":"Oncotarget"},{"key":"14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Guan","year":"2002","journal-title":"Nat Cell Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"Onda","year":"2002","journal-title":"Hum Mol Genet"},{"key":"16","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","article-title":"Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma","volume":"361","author":"Kwiatkowski","year":"2003","journal-title":"Lancet"},{"key":"17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Kwiatkowski","year":"2003","journal-title":"J Clin Invest"},{"key":"18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1172\/JCI28984","article-title":"PDGFRs are critical for PI3K\/Akt activation and negatively regulated by mTOR","volume":"117","author":"Kwiatkowski","year":"2007","journal-title":"J Clin Invest"},{"key":"19","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","article-title":"Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2","volume":"19","author":"Cantley","year":"2005","journal-title":"Genes Dev"},{"key":"20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2011.09.006","article-title":"TSC1\/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade","volume":"313","author":"Zhang","year":"2011","journal-title":"Cancer Lett"},{"key":"21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action androle of platelet-derived growth factor","volume":"79","author":"Westermark","year":"1999","journal-title":"Physiol Rev"},{"key":"22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Betsholtz","year":"2008","journal-title":"Genes Dev"},{"key":"23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1478-811X-11-97","article-title":"Targeting the PDGF signaling pathway in tumor treatment","volume":"11","author":"Heldin","year":"2013","journal-title":"Cell Commun Signal"},{"key":"24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/1538-7445.AM10-288","article-title":"PDGFR alpha and PDGFR beta differentially regulate cell proliferation and migration\/invasion in medulloblastoma cells","volume":"70","author":"Wu","year":"2010","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1096\/fj.08-113860","article-title":"Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability","volume":"23","author":"Wahlberg","year":"2009","journal-title":"FASEB J"},{"key":"26","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-12-1646","article-title":"Distinct effects of ligand-induced PDGFRalpha and PDGFRbeta signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments","volume":"73","author":"Eriksson","year":"2013","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI37964","article-title":"Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3\/p63\/Jagged\/Notch cascade","volume":"120","author":"Wang","year":"2010","journal-title":"J Clin Invest"},{"key":"28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/0008-5472.CAN-10-1668","article-title":"Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"28435","DOI":"10.18632\/oncotarget.8633","article-title":"mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency","volume":"7","author":"Zha","year":"2016","journal-title":"Oncotarget"},{"key":"30","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Goto","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"31","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/onc.2012.481","article-title":"mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development","volume":"32","author":"Walker","year":"2013","journal-title":"Oncogene"},{"key":"32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1748-1716.2007.01780.x","article-title":"FOXO transcription factors in ageing and cancer","volume":"192","author":"Brunet","year":"2008","journal-title":"Acta Physiol (Oxf)"},{"key":"33","doi-asserted-by":"publisher","first-page":"42110","DOI":"10.18632\/oncotarget.9881","article-title":"Pharmacological activation of FOXO3 suppresses triple-negative breast cancerand","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"34","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/onc.2008.24","article-title":"FOXOs, cancer and regulation of apoptosis","volume":"27","author":"Tindall","year":"2008","journal-title":"Oncogene"},{"key":"35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Cantley","year":"2007","journal-title":"Cell"},{"key":"36","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Thiele","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"37","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/hmg\/ddu597","article-title":"A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex","volume":"24","author":"Kwiatkowski","year":"2015","journal-title":"Hum Mol Genet"},{"key":"38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1378\/chest.14-3095","article-title":"Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec: Prevalence and Health-care Utilization","volume":"148","author":"Landry","year":"2015","journal-title":"Chest"},{"key":"39","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","article-title":"Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling","volume":"332","author":"Blenis","year":"2011","journal-title":"Science"},{"key":"40","first-page":"407","article-title":"Deficient TSC1\/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex","volume":"26","author":"Zha","year":"2017","journal-title":"Hum Mol Genet"},{"key":"41","doi-asserted-by":"crossref","first-page":"25756","DOI":"10.1074\/jbc.M115.665208","article-title":"Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis","volume":"290","author":"Zhang","year":"2015","journal-title":"J Biol Chem"},{"key":"42","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1073\/pnas.1119535109","article-title":"Regulation of neuroblastoma differentiation by forkhead transcription factors FOXO1\/3\/4 through the receptor tyrosine kinase PDGFRA","volume":"109","author":"You","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"43","doi-asserted-by":"crossref","first-page":"e88891","DOI":"10.1371\/journal.pone.0088891","article-title":"The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase","volume":"9","author":"Okada","year":"2014","journal-title":"PLoS One"},{"key":"44","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/onc.2008.21","article-title":"The FoxO code","volume":"27","author":"Brunet","year":"2008","journal-title":"Oncogene"},{"key":"45","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cmet.2013.09.013","article-title":"mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc","volume":"18","author":"Yang","year":"2013","journal-title":"Cell Metab"},{"key":"46","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"Sabatini","year":"2006","journal-title":"Dev Cell"},{"key":"47","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1073\/pnas.0602282103","article-title":"TSC1\/TSC2 and Rheb have different effects on TORC1 and TORC2 activity","volume":"103","author":"Guan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"48","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1-TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Manning","year":"2008","journal-title":"Mol Cell Biol"},{"key":"49","doi-asserted-by":"crossref","first-page":"e12293","DOI":"10.1371\/journal.pone.0012293","article-title":"Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer","volume":"5","author":"Lam","year":"2010","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1128\/MCB.01265-07","article-title":"The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase\/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression","volume":"28","author":"Lam","year":"2008","journal-title":"Mol Cell Biol"},{"key":"51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.devcel.2010.03.008","article-title":"FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor","volume":"18","author":"Hay","year":"2010","journal-title":"Dev Cell"},{"key":"52","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1158\/0008-5472.CAN-13-1729","article-title":"FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway","volume":"74","author":"Gan","year":"2014","journal-title":"Cancer Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/157015912804499537","article-title":"mTOR Inhibitors in Tuberous Sclerosis Complex","volume":"10","author":"Moavero","year":"2012","journal-title":"Curr Neuropharmacol"},{"key":"54","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.7150\/jca.14747","article-title":"Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?","volume":"7","author":"Liang","year":"2016","journal-title":"J Cancer"},{"key":"55","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.ophtha.2015.03.023","article-title":"Sirolimus for Retinal Astrocytic Hamartoma Associated with Tuberous Sclerosis Complex","volume":"122","author":"Xu","year":"2015","journal-title":"Ophthalmology"},{"key":"56","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Franz","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T06:40:44Z","timestamp":1750488044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,4]]},"references-count":56,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017,8,15]]}},"alternative-id":["18963","28903387"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18963","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,4]]}}}